quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:54:18·7d
SECFiling
Cybin Inc. logo

SEC Form 6-K filed by Cybin Inc.

HELP· Cybin Inc.
Health Care
Original source

Companies

  • HELP
    Cybin Inc.
    Health Care

Recent analyst ratings

  • Apr 13UpdateTD Cowen$8.00
  • Feb 2UpdateJefferies$22.00

Related

  • SEC6h
    SEC Form 6-K filed by Cybin Inc.
  • PR16h
    Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan
  • SEC1d
    Amendment: SEC Form SCHEDULE 13G/A filed by Cybin Inc.
  • SEC3d
    SEC Form 6-K filed by Cybin Inc.
  • SEC3d
    SEC Form 6-K filed by Cybin Inc.
  • PR3d
    Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions
  • PR3d
    Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer
  • PR7d
    Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022